We are excited to announce the groundbreaking of our new pharmaceutical manufacturing facility in Kinshasa, DRC!
This marks a monumental step in Shalina Healthcare’s ongoing commitment to delivering affordable, 𝐡𝐢𝐠𝐡-𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 to local communities across Africa.
With a state-of-the-art facility in the Kin Malebo, Zone économique spéciale, we are dedicated to meeting the growing healthcare needs of DRC and beyond.
This facility will manufacture over 𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐭𝐚𝐛𝐥𝐞𝐭𝐬, 𝟔𝟎𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐜𝐚𝐩𝐬𝐮𝐥𝐞𝐬, 𝐚𝐧𝐝 𝟐𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐬𝐲𝐫𝐮𝐩 𝐛𝐨𝐭𝐭𝐥𝐞𝐬 𝐚𝐧𝐧𝐮𝐚𝐥𝐥𝐲, bringing trusted brands such as Amidol, Ibucap, Anaflam, Tanzol and Hemoforce closer to patients.
The groundbreaking ceremony, held on 16 March 2026, was graced by 𝐌𝐫. 𝐂𝐡𝐫𝐢𝐬𝐭𝐢𝐚𝐧 𝐍𝐭𝐮𝐦𝐛𝐚 𝐍𝐠𝐨𝐲, 𝐃𝐆, 𝐀𝐂𝐎𝐑𝐄𝐏, 𝐚𝐬 𝐂𝐡𝐢𝐞𝐟 𝐆𝐮𝐞𝐬𝐭, 𝐭𝐡𝐞 𝐌𝐚𝐲𝐨𝐫𝐬, 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐯𝐞𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐌𝐢𝐧𝐢𝐬𝐭𝐫𝐲 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡, 𝐚𝐧𝐝 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫𝐬 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐟𝐫𝐨𝐦 𝐤𝐞𝐲 𝐠𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐛𝐨𝐝𝐢𝐞𝐬, reflecting strong government support.
“Today marks an important milestone in our mission to make healthcare more accessible and impactful. This new facility strengthens our resolve to 𝐞𝐦𝐩𝐨𝐰𝐞𝐫 𝐥𝐨𝐜𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞, create 𝐬𝐤𝐢𝐥𝐥𝐞𝐝 𝐞𝐦𝐩𝐥𝐨𝐲𝐦𝐞𝐧𝐭, and contribute to the 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 of the DRC.”
— 𝐌𝐫. 𝐀𝐛𝐛𝐚𝐬 𝐕𝐢𝐫𝐣𝐢, 𝐌𝐃, 𝐒𝐡𝐚𝐥𝐢𝐧𝐚 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞
“We are proud to support Shalina Healthcare’s initiative, which aligns with our vision of creating a sustainable healthcare landscape and 𝐢𝐦𝐩𝐫𝐨𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐥𝐢𝐯𝐞𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐞𝐨𝐩𝐥𝐞 in the DRC.”
— 𝐌𝐫. 𝐂𝐡𝐫𝐢𝐬𝐭𝐢𝐚𝐧 𝐍𝐭𝐮𝐦𝐛𝐚 𝐍𝐠𝐨𝐲, 𝐃𝐆, 𝐀𝐂𝐎𝐑𝐄𝐏
We look forward to continuing our journey to bring 𝐭𝐫𝐮𝐬𝐭𝐞𝐝, 𝐚𝐟𝐟𝐨𝐫𝐝𝐚𝐛𝐥𝐞 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 closer to the people who need them the most.
Stay tuned as we continue to make strides in our mission for a 𝐡𝐞𝐚𝐥𝐭𝐡𝐢𝐞𝐫 𝐭𝐨𝐦𝐨𝐫𝐫𝐨𝐰!
